Bumetanide and Dyslipidaemia - a phase IV clinical study of FDA data


Dyslipidaemia is found among people who take Bumetanide, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Bumetanide and have Dyslipidaemia. It is created by eHealthMe based on reports of 17,150 people who have side effects when taking Bumetanide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2022

17,150 people reported to have side effects when taking Bumetanide.
Among them, 10 people (0.06%) have Dyslipidaemia.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 17,317 Bumetanide users for its effectiveness, alternative drugs and more.

What is Dyslipidaemia?

Dyslipidaemia (abnormal amount of lipids) is found to be associated with 1,278 drugs and 677 conditions by eHealthMe.

Number of Bumetanide and Dyslipidaemia reports submitted per year:

Could Bumetanide cause Dyslipidaemia?

Gender of people who have Dyslipidaemia when taking Bumetanide *:

  • female: 88.89 %
  • male: 11.11 %

Age of people who have Dyslipidaemia when taking Bumetanide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 12.5 %
  • 50-59: 37.5 %
  • 60+: 50.0 %

Common drugs people take besides Bumetanide *:

  1. Pantoprazole: 4 people, 40.00%
  2. Lasix: 4 people, 40.00%
  3. Percocet: 3 people, 30.00%
  4. Lisinopril: 3 people, 30.00%
  5. Vistaril: 3 people, 30.00%
  6. Lipitor: 3 people, 30.00%
  7. Klor-Con: 3 people, 30.00%
  8. Imdur: 3 people, 30.00%
  9. Lansoprazole: 2 people, 20.00%
  10. Glipizide: 2 people, 20.00%

Common side effects people have besides Dyslipidaemia *:

  1. Weakness: 5 people, 50.00%
  2. Breathing Difficulty: 5 people, 50.00%
  3. Fatigue (feeling of tiredness): 5 people, 50.00%
  4. Stress And Anxiety: 4 people, 40.00%
  5. Diabetes: 4 people, 40.00%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 30.00%
  7. Headache (pain in head): 3 people, 30.00%
  8. Joint Swelling: 3 people, 30.00%
  9. Abdominal Distension: 3 people, 30.00%
  10. Cardiac Failure Congestive: 3 people, 30.00%

Common conditions people have *:

  1. Thyroid Diseases: 2 people, 20.00%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 20.00%
  3. Pain: 2 people, 20.00%
  4. Chest Pain: 2 people, 20.00%
  5. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 20.00%
  6. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 20.00%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 10.00%
  8. Cardiac Failure Chronic: 1 person, 10.00%
  9. Cardiomyopathy (weakening of the heart muscle): 1 person, 10.00%
  10. Constipation: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and have Dyslipidaemia?

Check whether Dyslipidaemia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Dyslipidaemia and when was it recovered:

Expand to all the drugs that have ingredients of bumetanide:

Alternative drugs to, pros and cons of Bumetanide:

Common Bumetanide side effects:

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Dyslipidaemia treatments and more:

COVID vaccines that are related to Dyslipidaemia:

Common drugs associated with Dyslipidaemia:

All the drugs that are associated with Dyslipidaemia:

Common conditions associated with Dyslipidaemia:

All the conditions that are associated with Dyslipidaemia:

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumetanide) and Bumetanide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: